Plus: predicting diabetes risk in men; teen BMIs
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

June 20, 2020 : Issue #1047

TOP STORIES - Diabetes News & Research

Study Provides Insight Into Dual and Triple Therapy Options for Diabetes

Predicting Diabetes Risk in Men

New Findings on the Relationship Between Teen BMIs and Diabetes
Letter from the Editor

For years the mantra in type 2 diabetes care was "start low go slow." This seemed to make sense when most patients were diagnosed in their late 50’s or early 60’s.

Now we see many new patients in their 30’s and 40’s, and so we need to get more aggressive in treatment. The question is, which medications should we mix together to get the maximum effect with the minimum risk? This week our University of Colorado intern David Clarke has the results of a large study that will help you decide which medications to select.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option
lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

TOP STORIES - Diabetes News and Research

Study Provides Insight Into Dual and Triple Therapy Options for Diabetes
Danish study makes strong recommendations for diabetes pharmacotherapy beyond metformin.
READ MORE
Predicting Diabetes Risk in Men
Lower percentages of lean body mass have shown correlation to a higher risk of diabetes in older men.
READ MORE
New Findings on the Relationship Between Teen BMIs and Diabetes
Body mass in adolescence affects risk of developing type 2 as an adult.
READ MORE

Did You Know? Eating late causes obesity:


In a study published on June 11 in The Journal of Clinical Endocrinology & Metabolism, researchers looked at consuming calories later in the day and how it affects obesity and metabolic syndrome. They hypothesized that eating a late dinner alters substrate metabolism during sleep in a manner that promotes obesity. This was a randomized crossover trial of late dinner versus routine dinner with a fixed sleep period in a laboratory setting, To examine the impact of late dinner on nocturnal metabolism in healthy volunteers, they took 20 healthy volunteers (10 males, 10 females), aged 26.0 ± 0.6 years, BMI 23.2 ± 0.7 kg/m2, accustomed to a bedtime between 22:00-01:00 to examine the impact of a late dinner on nocturnal metabolism. This is a randomized crossover trial of late dinner (LD, 22:00) versus routine dinner (RD, 18:00), with a fixed sleep period (23:00-07:00) in a laboratory setting. An isocaloric macronutrient diet was administered on both visits. Dinner (35% daily kcal, 50% carbohydrate, 35% fat) with an oral lipid tracer palmitate, 15 mg/kg) was given at 18:00 on RD and 22:00 on LD. Nocturnal and next-morning hourly plasma glucose, insulin, triglycerides, free fatty acids (FFAs), cortisol, dietary fatty acid oxidation, and overnight polysomnography were measured. The results showed that LD caused a 4-hour shift in the postprandial period, overlapping with the sleep phase. Independent of this shift, the postprandial period following LD was characterized by higher glucose, a triglyceride peak delay, and lower FFA and dietary fatty acid oxidation. LD did not affect sleep architecture but increased plasma cortisol. These metabolic changes were most pronounced in habitual earlier sleepers determined by actigraphy monitoring. It was concluded that LD induces nocturnal glucose intolerance, and reduces fatty acid oxidation and mobilization, particularly in earlier sleepers. These effects can promote obesity if they recur chronically. The Journal of Clinical Endocrinology & Metabolism

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

David Clarke, PharmD Candidate, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences

Sameen Khan, Pharm.D. Candidate, USF College of Pharmacy  

Maya Palmer, PharmD. Candidate, Florida A&M University College of Pharmacy

Jacob Roberts, PharmD Candidate 2021 of University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences 

Stephen Rubano, PharmD. Candidate, USF Taneja College of Pharmacy 

 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States


DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe